Xenon versus Desflurane anesthesia during cardioverter defribrillator implantation.
Recruiting
- Conditions
- decreased left ventricular function, cardioverter defribrillator, echocardiography
- Registration Number
- NL-OMON22512
- Lead Sponsor
- niversitair ziekenhuis Brussel
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
1. Patients scheduled for internal cardioverter defibrillator implantation;
2. A preoperative left ventricular ejection fraction < .4, as assessed on echocardiography or left ventricular angiography;
Exclusion Criteria
1. Patients with COPD, myocardial infarction < 3 m before surgery;
2. Withdrawal from the study is performed whenever a serious adverse event (e.g. major bleeding, shock or death) occurs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method V systolic function and contractility will be assessed.
- Secondary Outcome Measures
Name Time Method Postoperative problems, such as nausea, vomiting, changes of haemodynamics 20 % beyond baseline measurements, or hypoxia will be reported. Also postoperative nausea and vomiting, shivering dizziness, confusion etc. are stated as adverse events.